Cumberland Pharmaceuticals Inc. Proceeds from Common Stock Issued
Cumberland Pharmaceuticals Inc. (CPIX) reported Proceeds from Common Stock Issued of $4.72 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. proceeds from issuance of common stock for the quarter ending 2025-06-30 was $0.00.
- Cumberland Pharmaceuticals Inc. proceeds from issuance of common stock for the quarter ending 2025-03-31 was $4.72M.
- Cumberland Pharmaceuticals Inc. proceeds from issuance of common stock for the quarter ending 2019-09-30 was $0.00.
- Cumberland Pharmaceuticals Inc. proceeds from issuance of common stock for the quarter ending 2019-06-30 was $0.00.
- Cumberland Pharmaceuticals Inc. proceeds from issuance of common stock for fiscal 2025 was $4.72M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2025-12-31 | $4.72M 10-K · filed 2026-03-09 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | $4.72M derived: sum of 2 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $4.72M 10-Q · filed 2026-08-07 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $200.91K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $200.91K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $200.91K 10-Q · filed 2019-05-15 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |